HIV Diagnostics and Treatment Market Size, Share, Analysis, Industry Report and Forecast 2019-2025
The
global HIV diagnosis and treatment market is estimated to grow at a CAGR of
7.6%, during the forecast period. Rising incidence and prevalence rate of HIV
infection across the globe coupled with the technological development of
diagnostic tests, such as rapid CD4, EID test and regulatory authority such as
approval of POC (point of care testing) for detection of HIV), is driving the
market growth. According to the Joint United Nations Program on HIV and AIDS
(UNAID), more than 36.7 million people across the globe have HIV and around 1.8
million children had HIV infection in 2017. The FDA performed the clinical
value of HIV diagnostic assay and blood screening and regulates the study to
create product standard and incorporated enhanced diagnostic methods to enables
the safety of drugs and biologics. The multidisciplinary research program plays
a vital role in the establishment of test kits, vaccines, therapeutics agents
for utilization in AIDS. Government support will support the growth of the HIV
diagnostics and treatment market.
Request
a Free Sample of our HIV Diagnostics and Treatment
Market:
https://www.omrglobal.com/request-sample/hiv-diagnostics-and-treatment-market
The
HIV diagnosis and treatment market is growing due to government initiatives,
rising awareness about HIV and growing number of blood donation is the reason
for the increase in a number of AIDs infection. It is a basic requirement for
the treatment of HIV in underdeveloped nation need for technological equipment;
however, the scarcity of funds and inaccuracy of the tests and with unskilled
professionals are hampering the market growth of HIV diagnostics and treatment
market.
A
full Report of HIV Diagnostics and Treatment
Market is
Available at: https://www.omrglobal.com/industry-reports/hiv-diagnostics-and-treatment-market
Global HIV
Diagnostics and Treatment Market
Segmentation
By Test Type
·
Antibody Tests
·
HIV-1 Screening Tests
·
HIV-1 Antibody Confirmatory Tests
·
HIV-2 & Group O Diagnostics Tests
·
Viral Identification Assays
·
CD4 Testing
·
Viral Load Testing
·
Early Infant Diagnostics
By Diagnostics Products
·
Kits and Reagents
·
Instruments
By Treatment
·
Non-Nucleoside Reverse Transcriptase Inhibitors
(NNRTIS)
·
Nucleoside or Nucleotide Reverse Transcriptase
Inhibitors (NRTIS)
·
Integrase Inhibitors
·
Others (Protease Inhibitors (PIS))
By End-User
·
Diagnostics Laboratory
·
Hospitals
·
Blood Banks
·
Home Care Settings
·
Others (Academic and Research Institutes)
Regional Analysis
·
North America
·
United States
·
Canada
·
Europe
·
UK
·
Germany
·
Italy
·
Spain
·
France
·
Rest of Europe
·
Asia-Pacific
·
China
·
India
·
Japan
·
Rest of Asia-Pacific
·
Rest of the World
Company
Profiles
·
Abbott Laboratories
·
AbbVie Inc.
·
Becton, Dickinson and Co.
·
Bio-Rad Laboratories, Inc.
·
bioMérieux SA
·
Boehringer Ingelheim International GmbH
·
Bristol-Myers Squibb Co.
·
Cipla Inc.
·
F. Hoffmann-La Roche Ltd.
·
Gilead Sciences, Inc.
·
GlaxoSmithKline PLC
·
Hologic, Inc.
·
Johnson & Johnson Services, Inc.
·
Merck & Co., Inc.
·
Mylan N.V.
·
Pfizer Inc.
·
QIAGEN N.V.
·
Siemens AG
·
Sysmex Corp.
·
ViiV Healthcare
For
More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hiv-diagnostics-and-treatment-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Contact
no: +91 7803040404
Comments
Post a Comment